Prevention and treatment of rheumatic heart disease in the developing world.
about
Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania.Disease appearance and evolution against a background of climate change and reduced resources.Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort studyClinical significance of markers of collagen metabolism in rheumatic mitral valve disease.Rheumatic Heart Disease-Attributable Mortality at Ages 5-69 Years in Fiji: A Five-Year, National, Population-Based Record-Linkage Cohort StudyImpact of MIF Gene Promoter Variations on Risk of Rheumatic Heart Disease and Its Age of Onset in Saudi Arabian Patients.Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverageScreening for rheumatic heart disease: current approaches and controversies.Rheumatic Heart Disease in the Twenty-First Century.Prevalence of rheumatic heart disease among school-children in Aden, Yemen.Historical aspects of rheumatic fever.[Rheumatic heart disease: future prospects].Automated signal quality assessment of mobile phone-recorded heart sound signals.Zinc'ing it out: zinc homeostasis mechanisms and their impact on the pathogenesis of human pathogen group A streptococcus.Meta-analysis of the relationship between single nucleotide polymorphism of IL-10-1082G/A and rheumatic heart disease.
P2860
Q33705559-13BEF3B6-F350-4E78-8A1F-D254C8C3D1ABQ33862234-A2CACACE-B978-4EF7-AD20-00480FAB3695Q34583247-27D3ADA7-85AF-4051-94E1-74A591F48D7FQ35113410-46D2C99D-4712-4685-B900-CE1DDD3FD387Q35775746-529FFFBB-6746-4F17-9DF2-4E8E86417E69Q36683165-A80D6A9A-4CF8-4D56-B164-1E67E53C44A5Q37625963-01245AC8-6097-4A1F-B8B8-3C1114B3EBB2Q38059617-40ACEFC7-A45A-4FD1-A583-8E68A5446665Q38377791-2D199FD3-487F-4E15-9FE4-93260CBB9721Q39196531-7436EC9A-96D5-46C2-B5E9-23D84C1A0F0FQ40173912-F80F22EC-944F-49A4-A213-74CBF9021CEBQ40280316-528AC7BE-407A-4DC5-A362-B65715C1F8D0Q40407265-B694C307-A3A6-42C4-8E02-C4CF7A370F88Q48172297-0EDAEA70-F53C-4217-AFD0-9F159082A95EQ52649585-47E04545-BCFC-4F1A-852D-920D3FCA0E70
P2860
Prevention and treatment of rheumatic heart disease in the developing world.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention and treatment of rheumatic heart disease in the developing world.
@en
Prevention and treatment of rheumatic heart disease in the developing world.
@nl
type
label
Prevention and treatment of rheumatic heart disease in the developing world.
@en
Prevention and treatment of rheumatic heart disease in the developing world.
@nl
prefLabel
Prevention and treatment of rheumatic heart disease in the developing world.
@en
Prevention and treatment of rheumatic heart disease in the developing world.
@nl
P2860
P1476
Prevention and treatment of rheumatic heart disease in the developing world.
@en
P2093
Andrew C Steer
Jonathan R Carapetis
P2860
P304
P356
10.1038/NRCARDIO.2009.162
P407
P577
2009-09-15T00:00:00Z